Hannah Linden

HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab

Shanu Modi, Alison Stopeck, Hannah Linden et al. · Clinical Cancer Research · 2011 · 418 citations

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)

Priyanka Sharma, William E. Barlow, Andrew K. Godwin et al. · Annals of Oncology · 2017 · 119 citations · Full text

Myalgias and arthralgias associated with paclitaxel.

Julie A. Garrison, Jeannine S. McCune, Robert B. Livingston et al. · PubMed · 2003 · 42 citations

Weekly Paclitaxel Administration, Anti-inflammatory, Pain Medicine +13

Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors

Helen K. Chew, George Somlo, Philip C. Mack et al. · Annals of Oncology · 2011 · 15 citations · Full text

Oncology, Solid Tumors, Medicine +7

Phase I: Veliparib with cisplatin (CP) and vinorelbine (VNR) in advanced triple-negative breast cancer (TNBC) and/or <i>BRCA</i> mutation-associated breast cancer.

Eve T. Rodler, Julie R. Gralow, Brenda F. Kurland et al. · Journal of Clinical Oncology · 2014 · 15 citations

Breast Oncology, Chemoprevention Strategy, Dna Repair Defects +18